| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Director | Common Stock | 10.7K | $1.3M | $121.18 | Mar 14, 2025 | Direct |
| INCYTE CORP | Director | Common Stock | 11.3K | $685K | $60.85 | Jun 10, 2025 | Direct |
| Lyell Immunopharma, Inc. | Director | Common Stock | 35.6K | $16.8K | $0.47 | May 15, 2025 | Direct |
| Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130K | May 15, 2025 | Direct | ||
| Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130K | Jun 14, 2024 | Direct | ||
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 22.7K | Jun 11, 2025 | Direct | ||
| INCYTE CORP | Director | Non Qualfied Stock Option (right to buy) | 9.22K | Jun 10, 2025 | Direct | ||
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 9K | Jun 24, 2024 | Direct |